WVU’s Cancer Center to host regional conference

MORGANTOWN, W.Va. – The West Virginia University Mary Babb Randolph Cancer Center (MBRCC) will host a conference for cancer physicians and scientists from ten regional cancer centers on Feb. 21st and 22nd. 

The 11th annual meeting of the Translational Research Cancer Center Consortium (TRC3) will bring together cancer experts from Ohio, Pennsylvania, New York, Michigan and West Virginia.

“The TRC3 annual meeting is a great opportunity for WVU’s basic science and clinical researchers to share and exchange information with colleagues in the region’s cancer centers,” said William Petros, Pharm.D., associate director of anti-cancer drug development at MBRCC.  

“Targeting the Tumor Microenvironment” is the theme of this year’s conference. 
The conference will also focus on implementing clinical trials to test new medical treatments, technologies and other interventions among the region’s cancer centers. 

One of WVU’s presenters will be Ray Raylman, Ph.D., vice chair of radiology research at the MBRCC.  Dr. Raylman and colleagues at WVU have developed a new medical imaging device that can detect very small breast tumors, even in dense breasts.  The PEM/PET system could help women avoid unnecessary biopsies.

“By exchanging research knowledge with colleagues throughout the region, we can build a stronger research infrastructure that will help all of us advance and enhance patient care,” said Scot C. Remick, M.D., director of the MBRCC.  “I look forward to any new collaborations or ideas that come from sharing resources that may arise from the TRC3 meeting.”

Medical oncologists, scientists, fellows, and students interested in receiving continuing education credits for the meeting can also register online at the same web site.

For more information about the Translational Research Cancer Center Consortium visit http://www.hsc.wvu.edu/mbrcc/trc3/.

- WVU -

For more information:
Sherry Stoneking, Cancer Center, (304) 293-4599
sls: 02/19/08

Return To News Releases